ClinicalTrials.Veeva

Menu

Minnesota RETAIN Impact Evaluation

M

Mathematica Policy Research

Status

Enrolling

Conditions

Any Injury or Illness Acutely Impacting Work

Treatments

Other: Minnesota RETAIN

Study type

Interventional

Funder types

Other

Identifiers

NCT05146349
RTN-MN
OD-32543-18-75-4-27 (Other Grant/Funding Number)

Details and patient eligibility

About

This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. Collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay at work and return to work will be implemented.

Full description

MN RETAIN is a collaborative program led by the Minnesota Department of Employment and Economic Development (DEED), Minnesota Department of Health (MDH), Department of Labor and Industry (DLI), Mayo Clinic, and Workforce Development Inc (WDI) and includes stakeholders throughout MN.

Enrollment

3,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must have been unable to work for no more than 6 months prior enrollment; 80% of participants must be within 3 months of their last day of work

  • 18 years or older

  • Minnesota resident

  • Works in Minnesota

  • Employed or currently in the labor force

  • Meets one of the following:

    1. Diagnosis of a work related or personal injury or illness that impacts employment
    2. Invasive procedure (e.g., surgery) within the past 12-weeks or anticipated within the next 8-weeks that impacts employment

Exclusion criteria

  • Legal representation/litigation at the time of enrollment related to their medical condition.
  • Does not have the capacity to give appropriate informed consent
  • Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e. Mayo Clinic employees)
  • Worker's compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3,200 participants in 2 patient groups

RETAIN Programming
Experimental group
Description:
The experimental group receives the full set of RETAIN intervention activities.
Treatment:
Other: Minnesota RETAIN
Control
No Intervention group
Description:
The control group does not receive the full set of RETAIN intervention activities.

Trial contacts and locations

1

Loading...

Central trial contact

Amaka Osuoha, MPH; Catherine Turvey, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems